Your browser doesn't support javascript.
loading
Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China.
Liu, Y; Sun, Y; Zhang, X; Zhang, Z; Xing, Q; Ren, W; Yao, C; Yu, J; Ding, B; Wang, S; Li, C.
Afiliação
  • Liu Y; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing101149, China.
  • Sun Y; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing101149, China.
  • Zhang X; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing101149, China.
  • Zhang Z; Beijing Changping Center for Tuberculosis Control and Prevention, Changping District, Beijing102200, China.
  • Xing Q; Central Laboratory, Beijing Research Institute for Tuberculosis Control, Xicheng District, Beijing100035, China.
  • Ren W; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing101149, China.
  • Yao C; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing101149, China.
  • Yu J; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing101149, China.
  • Ding B; Central Laboratory, Beijing Research Institute for Tuberculosis Control, Xicheng District, Beijing100035, China.
  • Wang S; Central Laboratory, Beijing Research Institute for Tuberculosis Control, Xicheng District, Beijing100035, China.
  • Li C; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing101149, China.
Epidemiol Infect ; 149: e21, 2021 01 05.
Article em En | MEDLINE | ID: mdl-33397543
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxirredutases / Proteínas de Bactérias / Catalase / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Epidemiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / EPIDEMIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxirredutases / Proteínas de Bactérias / Catalase / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Epidemiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / EPIDEMIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China